Stay updated with breaking news from Eqs Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences's commercial roll-out of MagnetOs bone graft exceeds expectations 02-Jun-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this a...
EQS Group-Ad-hoc: Lonza Group AG / Key word(s): Agreement/Expansion Lonza and Moderna Announce Further Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands
EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences's commercial roll-out of MagnetOs bone graft exceeds expectations 02-Jun-2021 / 07:00 CET/CEST Release of an
EQS Group-Ad-hoc: Lonza Group AG / Key word(s): Agreement/Expansion Lonza and Moderna Announce Further Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands 02-Jun-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is...
EQS-Adhoc: HBM Healthcare Investments AG: Key Figures 31.05.2021 Key Figures 31.05.2021 Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. in CHF 2'146 Fax +41 41 710 75 78 E-Mail: hbm@hbmhealthcare.com Should you wish to unsubscribe from all HBM Healthcare Investments news, please unsubscribe here. Disclaimer: This message may contain confidential or privileged Information and is intended only for the use of the addressee named above. If you are not the intended recipient of this message, you are hereby notified t...